Universe Pharmaceuticals Inc (UPC) Financials

$4.81

$0.45 (10.32%)

As on 14-Sep-2026 16:00EDT

Market cap

$22 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Cash From Operating Activities	-5.05	-9.51	1.12	-1.31	-2.06	6.12
Cash Flow from Investing Activities	-0.34	--	-0.04	-3.91	-27.06	-0.05
Cash from Financing Activities	9.73	33.95	-1.39	3.32	26.58	0.47
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Adjusted EPS ($)	-1,049.16	-1,430.70	-1,044.59	-0.40	0.52	1,303.14
Cash EPS ($)	-901.32	-1,351.08	-958.35	-0.38	0.54	1,373.85
Adjusted Book Value ($)	16,037.00	7,459.50	6,700.46	2.14	2.71	3,586.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1,443.52	-1,558.47	189.84	-0.06	-0.09	1,054.34
Free Cash Flow per Share ($)	-1,542.72	-1,618.00	182.36	-0.06	-0.72	1,045.41

Profitability Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
ROCE (%)	-6.62	-19.28	-12.92	-15.37	26.11	39.41
ROE (%)	-7.23	-20.53	-14.34	-16.58	28.39	45.55
ROA (%)	-5.35	-14.40	-10.92	-13.47	22.88	32.41
EBIT Margin (%)	-19.26	-34.83	-11.43	-17.27	28.66	33.23
Net Margin (%)	-20.56	-37.90	-19.08	-21.76	23.59	24.62
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Revenue Growth (%)	-0.22	-0.29	-0.20	-0.16	0.56	-0.08
EBIT Growth (%)	57.11	-117.18	46.73	-150.42	34.77	4.58
Net Profit Growth (%)	57.92	-41.61	29.46	-177.18	49.77	0.09
EPS Growth (%)	0.27	-0.37	-2,599.54	-1.77	-1.00	0.00
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Price / Earnings	0.00	0.00	0.00	-1.41	4.75	--
Price / Book Value	0.00	0.00	0.00	0.26	0.91	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	8.32	--	4.09	0.41	2.55	--
Close Price ($)	4.20	3.66	14.25	50.85	222.30	--
High Price ($)	15.00	64.80	187.20	229.50	1,079.10	--
Low Price ($)	0.08	3.36	13.65	45.02	200.70	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debt to Equity	0.16	--	0.14	0.08	0.07	0.13
Short term debt to equity ratio	0.16	--	0.14	0.08	0.07	0.13
Current Ratio	4.07	2.54	2.68	3.17	4.50	2.85
Quick Ratio	3.90	2.46	2.43	3.00	4.28	2.62
Interest Coverage	-14.83	-28.83	-23.55	-42.68	135.32	82.44

Operating Efficiency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debtors to sales (%)	73.84	56.05	33.21	37.82	32.95	35.41
Asset Turnover	0.26	0.38	0.57	0.62	0.97	1.32
Receivable days	266.82	187.47	146.47	141.01	101.56	102.86
Inventory Days	62.10	54.73	46.08	46.72	35.22	49.71
Payable days	104.04	102.34	63.61	83.91	64.50	50.89
Cash Conversion Cycle	224.88	139.86	128.95	103.81	72.27	101.68